Diabetes, obesity & metabolism

The most recent articles from: Diabetes Obes Metab March 2019

Diabetes Obes Metab · Mar 2019

Randomized Controlled Trial Multicenter Study

Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial.

To assess the cardiovascular (CV) safety of oral semaglutide, the first tablet formulation of a glucagon-like peptide-1 receptor agonist. ⋯ PIONEER 6 will provide evidence regarding the CV safety of oral semaglutide in patients with type 2 diabetes and high CV risk.

read more… or not…

Want more great medical articles?

Keep up to date with a free trial of metajournal, personalized for your practice.
1,706,662 articles already indexed!